The Pharmaceutical Journal
Vol 280 No 7484 p12-13
5/12 January 2008

This article
Reprint   Photocopy

PDF 60K, Acrobat Reader

Announcements

• Meropenem SPC
• Schwartz products
• University of Bradford

Announcements

Meropenem SPC
Information about dosing for renally impaired patients is incorrect in printed versions of the summary of product characteristics for Meropenem (meronem). AstraZeneca has written to healthcare professionals to make them aware of the error.

The correct dose for patients with creatinine clearance of 26–50 is one unit dose every 12 hours.

For patients with creatinine clearance of 10–25 it is one half-unit dose every 12 hours.

For patients with creatinine clearance of <10 it is one half-unit dose every 24 hours.

Correct dosing information is available on all Meropenem packs, in the British National Formulary and at www.medicines.org.uk

Further information is available on 0800 7830033

Schwartz products
Following acquisition of Schwarz Pharma Ltd by UCB Pharma Ltd all Schwarz products will be available from UCB from 2 January 2008.

Customer services on 01753 534655

University of Bradford
Carole Brown has been awarded a postgraduate master’s degree in clinical pharmacy (community) with merit by the University of Bradford’s School of Pharmacy.

The following pharmacists have been awarded the postgraduate diploma in clinical pharmacy (community):

• Michael Child (with distinction)
• Khurshid Choudhry (with merit)
• Christine Grundy (with distinction)
• April Hann (with merit)
• Zulfiqar Jafry
• Roselyn Kankondo (with merit)
• Ashwanth Singh
• Raman Sharma (with merit)

The following pharmacists have been awarded the postgraduate certificate in clinical pharmacy (community):

• Kathleen Aspin (with distinction)
• Asharat Khaliq